Aveo Oncology

Aveo Oncology company information, Employees & Contact Information

Explore related pages

Related company profiles:

AVEO is a commercial-stage, oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer. AVEO currently markets FOTIVDA® (tivozanib) in the U.S. for the treatment of adult patients with relapsed or refractory renal cell carcinoma (RCC) following two or more prior systemic therapies. AVEO continues to develop FOTIVDA in immuno-oncology combinations in RCC and other indications, and has other investigational programs in clinical development. AVEO is committed to creating an environment of diversity, equity and inclusion to diversify representation within the Company.

Company Details

Employees
200
Founded
-
Address
30 Winter St,
Phone
(617) 588-1960
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
Oncology.
HQ
Boston, Massachusetts
Looking for a particular Aveo Oncology employee's phone or email?

Aveo Oncology Questions

News

AVEO Oncology, an LG Chem company, Announces Three Poster Presentations at ASCO 2025 Annual Meeting - PR Newswire

AVEO Oncology, an LG Chem company, Announces Three Poster Presentations at ASCO 2025 Annual Meeting PR Newswire

Adding nivolumab to low-dose tivozanib does not improve PFS in renal cell carcinoma - Urology Times

Adding nivolumab to low-dose tivozanib does not improve PFS in renal cell carcinoma Urology Times

AVEO Oncology Announces Participation at Two Upcoming Investor Conferences - Stock Titan

AVEO Oncology Announces Participation at Two Upcoming Investor Conferences Stock Titan

AVEO Oncology kidney cancer combo fails at Phase III - Clinical Trials Arena

AVEO Oncology kidney cancer combo fails at Phase III Clinical Trials Arena

LG Chem to Acquire AVEO Oncology for $15.00 Per Share in Cash - GlobeNewswire

LG Chem to Acquire AVEO Oncology for $15.00 Per Share in Cash GlobeNewswire

LG Chem Completes Acquisition of AVEO Oncology - Yahoo Finance

LG Chem Completes Acquisition of AVEO Oncology Yahoo Finance

Results announced from a preclinical study of AV-380 for the treatment of cancer associated cachexia - Drug Target Review

Results announced from a preclinical study of AV-380 for the treatment of cancer associated cachexia Drug Target Review

LG Chem’s New US Acquisition AVEO Oncology Sets Sights On Being Global Top 20 Innovative Oncology Company - Business Wire

LG Chem’s New US Acquisition AVEO Oncology Sets Sights On Being Global Top 20 Innovative Oncology Company Business Wire

Top Aveo Oncology Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant